SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
___________________
Date of Report (Date of earliest event reported) January 19, 1999
BIOCONTROL TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
Pennsylvania 0-10822 25-1229323
(State of other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
300 Indian Springs Road, Indiana, Pennsylvania 15701
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (412) 349-1811
_________________________________________________________________
(Former name or former address,
if changes since last report.)
Item 1. Change in Control of Registrant.
Not applicable.
Item 2. Acquisition or Disposition of Assets.
Not applicable.
Item 3. Bankruptcy or Receivership.
Not applicable.
Item 4. Changes in Registrant's Certifying Accountant
Not applicable.
Item 5. Other Events.
On January 19, 1999 Biocontrol Tecnology, Inc.
announced that its subsidiary Diasense, Inc., which owns the
technology and marketing rights to the Diasensor1r 1000
noninvasive glucose sensor, is changing its corporate name to
Diasensor.com, Inc. The change is being made as part of a new
internet marketing plan that will wrap the Diasensor 1000 into an
overall diabetic care program utilizing the Diasensor for
internet transfer of extensive patient data stored in the device.
Item 6. Resignation of Registrant's Directors.
Not Applicable
Item 7. Financial Statement, Pro Forma Financial Information
and Exhibits.
(a) Financial Statements and Businesses Acquired -
Not Applicable.
(b) Pro Forma Financial Information - Not Applicable.
(c) Exhibits - Press Release.
SIGNATURES
Pursuant to the requirement of the Securities Exchange Act
of 1934, the Registrant has duly caused this Report to be signed
on its behalf by the undersigned hereunto duly authorized.
BIOCONTROL TECHNOLOGY, INC.
by /s/ Fred E. Cooper
Fred E. Cooper, CEO
DATED: January 19, 1999
BICO
BIOCONTROL TECHNOLOGY, INC
2275 Swallow Hill Road, Building 2500
Pittsburgh, PA 15220
Press Release
Investors Media
Diane McQuaide Susan Taylor
1.412.429.0673 phone 1.412.429.0673 phone
1.412.279.9690 fax 1.412.279.5041 fax
BIOCONTROL SUBSIDIARY DIASENSE, INC. TO UNDERGO NAME CHANGE AS
PART OF NEW INTERNET MARKETING PLAN
Pittsburgh, PA - January 19, 1999 - Biocontrol Technology,
Inc. (OTCBB:BICO) announced today that its subsidiary Diasense,
Inc., which owns the technology and marketing rights to the
Diasensorr1000 noninvasive glucose sensor, is changing its
corporate name to Diasensor.com, Inc. The change is being made
as part of a new internet marketing plan that will wrap the
Diasensor 1000 into an overall diabetic care program utilizing
the Diasensor for internet transfer of extensive patient data
stored in the device.
The Company has registered the domain name www.diasensor.com
where an interactive website will be developed to assist in the
marketing of this innovative concept.
Once the plan is finalized, further details will be
released.
Biocontrol Technology has its corporate offices in
Pittsburgh, PA and is involved in the development and manufacture
of biomedical devices and environmental products. Also located
in Pittsburgh, PA, Diasense is a subsidiary of Biocontrol
Technology and owns the patent, marketing and distribution rights
to the sensor. Biocontrol has the exclusive rights to the
research and development and manufacturing of the sensor.
WEBSITE: www.bico.com
INVESTOR RELATIONS NEWSLINE NUMBER: 1.800.357.6204
_______________________________
1
